Home
>
National Drug Code (NDC)
>
COMETRIQ
COMETRIQ - 42388-014-25 - (cabozantinib)
Drug Information of COMETRIQ
| Product NDC: | 42388-014 |
| Proprietary Name: | COMETRIQ |
| Non Proprietary Name: | cabozantinib |
| Active Ingredient(s): | 20 mg/1 & nbsp; cabozantinib |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of COMETRIQ
| Product NDC: | 42388-014 |
| Labeler Name: | Exelixis, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203756 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121129 |
Package Information of COMETRIQ
| Package NDC: | 42388-014-25 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (42388-014-25) |
NDC Information of COMETRIQ
| NDC Code | 42388-014-25 |
| Proprietary Name | COMETRIQ |
| Package Description | 60 CAPSULE in 1 BOTTLE (42388-014-25) |
| Product NDC | 42388-014 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cabozantinib |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20121129 |
| Marketing Category Name | NDA |
| Labeler Name | Exelixis, Inc. |
| Substance Name | CABOZANTINIB S-MALATE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
